Genentech, a subsidiary of the Roche Group, has unveiled plans to invest more than $700 million in a new 700,000 square foot state-of-the-art drug manufacturing facility in Holly Springs, North Carolina.
The project will add more than 400 high-wage manufacturing jobs when the site is operational and more than 1,500 construction jobs during site development.
The new facility will ultimately support Roche and Genentech’s future portfolio of next-generation obesity medicines and this initial investment could expand in the future based on business needs and the US policy environment. [Read more…] about Roche and Genentech to spend $700 million building new manufacturing facility